Article Details

Theravance Biopharma (NASDAQ:TBPH) Stock Rating Lowered by Zacks Investment Research

Retrieved on: 2021-01-18 14:51:53

Tags for this article:

Click the tags to see associated articles and topics

Theravance Biopharma (NASDAQ:TBPH) Stock Rating Lowered by Zacks Investment Research. View article details on hiswai:

Excerpt

Theravance Biopharma (NASDAQ:TBPH) last issued its quarterly earnings data on Thursday, November 5th. The biopharmaceutical company reported ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up